Search research articles
Contact Us
Filters
Showing results (11-20 of 67) with videos related to
Page
of 7
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
April 1, 1986
Plasma concentrations of flunitrazepam (Rohypnol) following oral and sublingual administration
M S Hüttel, U Bang, H Flachs
Kidney International
|
April 1, 1988
Analysis of the plasminogen activator activity of the human glomerulus
J M Bergstein, M Riley, N U Bang
Acta Anaesthesiologica Scandinavica
|
October 1, 1990
The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase
U Bang, J Viby-Mogensen, J E Wirén
The New England Journal of Medicine
|
September 10, 1992
Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome
J M Bergstein, M Riley, N U Bang
The American Journal of Medicine
|
September 1, 1982
Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome
J M Bergstein, U Kuederli, N U Bang
British Journal of Clinical Pharmacology
|
June 27, 1998
Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase
U Bang, L Nyberg, J Rosenborg, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
July 1, 1993
Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombin
J F Parkinson, N U Bang, J G Garcia
Acta Medica Scandinavica
|
January 1, 1985
Investigation of TSH dependency, circulating thyroid autoantibody, and morphological features of recurrent nontoxic goitre
S Husby, M Blichert-Toft, U Bang, et al.
Biochemical and Biophysical Research Communications
|
May 31, 1990
Decreased thrombin affinity of cell-surface thrombomodulin following treatment of cultured endothelial cells with beta-D-xyloside
J F Parkinson, J G Garcia, N U Bang
American Journal of Hematology
|
June 22, 2000
Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis
X Y Liu, T G Gabig, N U Bang
Page
of 7
Search research articles
Search
Showing results (11-20 of 67) with videos related to
Sort By:
Page
of 7
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
April 1, 1986
Plasma concentrations of flunitrazepam (Rohypnol) following oral and sublingual administration
M S Hüttel, U Bang, H Flachs
Kidney International
|
April 1, 1988
Analysis of the plasminogen activator activity of the human glomerulus
J M Bergstein, M Riley, N U Bang
Acta Anaesthesiologica Scandinavica
|
October 1, 1990
The effect of bambuterol on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in subjects heterozygous for abnormal plasma cholinesterase
U Bang, J Viby-Mogensen, J E Wirén
The New England Journal of Medicine
|
September 10, 1992
Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome
J M Bergstein, M Riley, N U Bang
The American Journal of Medicine
|
September 1, 1982
Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome
J M Bergstein, U Kuederli, N U Bang
British Journal of Clinical Pharmacology
|
June 27, 1998
Pharmacokinetics of bambuterol in subjects homozygous for the atypical gene for plasma cholinesterase
U Bang, L Nyberg, J Rosenborg, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
July 1, 1993
Recombinant human thrombomodulin attenuates human endothelial cell activation by human thrombin
J F Parkinson, N U Bang, J G Garcia
Acta Medica Scandinavica
|
January 1, 1985
Investigation of TSH dependency, circulating thyroid autoantibody, and morphological features of recurrent nontoxic goitre
S Husby, M Blichert-Toft, U Bang, et al.
Biochemical and Biophysical Research Communications
|
May 31, 1990
Decreased thrombin affinity of cell-surface thrombomodulin following treatment of cultured endothelial cells with beta-D-xyloside
J F Parkinson, J G Garcia, N U Bang
American Journal of Hematology
|
June 22, 2000
Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis
X Y Liu, T G Gabig, N U Bang
Page
of 7